Lisgar Collegiate Institute

Clover Health Launches in Florida in Partnership with ValueH

Retrieved on: 
Tuesday, August 3, 2021
Articles, Health, Health care quality, Health Economics, Chamath Palihapitiya, Lisgar Collegiate Institute, Health equity, Clover

NASHVILLE, Tenn., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq: CLOV) (“Clover”), an innovative technology company committed to improving health equity for America’s underserved seniors, announced a strategic partnership with ValueH, a leading member organization focused on Value-Based Care. Through the arrangement, ValueH will support Accountable Care Organizations (ACOs) and Management Services Organizations (MSOs) participating in Clover’s Direct Contracting Entity beginning in 2022.

Key Points: 
  • NASHVILLE, Tenn., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq: CLOV) (Clover), an innovative technology company committed to improving health equity for Americas underserved seniors, announced a strategic partnership with ValueH , a leading member organization focused on Value-Based Care.
  • Clovers DCE will enable providers to manage the care of their Original Medicare patients with the Clover Assistant.
  • Our partnership with Clover allows us to continue to champion independent practices while enhancing each entitys ability to make measurable improvements in care.
  • Clover Health (Nasdaq: CLOV) is a next-generation risk-bearing organization aiming to achieve health equity for all Americans.

Clover Health today announces that Joe Wagner, Chief Financial Officer, will leave the company on August 13th

Retrieved on: 
Thursday, July 15, 2021
Finance, Chamath Palihapitiya, Lisgar Collegiate Institute, NASDAQ, Clover, CLO, Investment, Economy of the United States

NASHVILLE, Tenn., July 15, 2021 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) (Clover) today announced that Joseph Wagner, its Chief Financial Officer, will be leaving the company on August 13th for personal reasons described below.

Key Points: 
  • NASHVILLE, Tenn., July 15, 2021 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) (Clover) today announced that Joseph Wagner, its Chief Financial Officer, will be leaving the company on August 13th for personal reasons described below.
  • Clover has engaged a leading executive search firm to find a Chief Financial Officer for the next stage of the Companys growth.
  • Vivek Garipalli, Clover Healths Chief Executive Officer, said, On behalf of Clover, I want to personally thank Joe for his hard work navigating the COVID-19 pandemic while simultaneously taking Clover public.
  • Clover Health (Nasdaq: CLOV) is a next-generation risk-bearing organization aiming to achieve health equity for all Americans.

Shareholder Alert: Robbins LLP is Investigating Clover Health Investments, Corp. (CLOV) on Behalf of Shareholders

Retrieved on: 
Monday, May 10, 2021
Legal, Professional services, Finance, Chamath Palihapitiya, Lisgar Collegiate Institute, NASDAQ, Clover, Investment, Economy of the United States

b'Shareholder rights law firm Robbins LLP is investigating Clover Health Investments, Corp. (NASDAQ: CLOV) on behalf of shareholders to determine whether certain Clover officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company.

Key Points: 
  • b'Shareholder rights law firm Robbins LLP is investigating Clover Health Investments, Corp. (NASDAQ: CLOV) on behalf of shareholders to determine whether certain Clover officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company.
  • Clover Health provides medical insurance services.\nIf you suffered a loss due to Clover Health Investment Corp.\'s misconduct, click here .\nAccording to a class action complaint filed against Clover Health, on October 6, 2020, the Company issued a press release announcing plans to become a publicly traded company via a merger with Social Capital Hedosophia Holdings Corp. III ("SCH").
  • On this news, shares of Clover dropped more than 12% from $13.95 on February 3, 2021, to $12.23 on February 4, 2021, representing a loss of $700 million in market capitalization.
  • The stock continued to tumble and now trades at just $8.40.\nContact us to learn more:\n'

Shareholder Alert: Robbins LLP is Investigating Clover Health Investments, Corp. (CLOV) on Behalf of Shareholders

Retrieved on: 
Friday, April 23, 2021
Legal, Professional services, Finance, Chamath Palihapitiya, Lisgar Collegiate Institute, NASDAQ, Clover, Investment, Economy of the United States

b'Shareholder rights law firm Robbins LLP is investigating Clover Health Investments, Corp. (NASDAQ: CLOV) on behalf of shareholders to determine whether certain Clover officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company.

Key Points: 
  • b'Shareholder rights law firm Robbins LLP is investigating Clover Health Investments, Corp. (NASDAQ: CLOV) on behalf of shareholders to determine whether certain Clover officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company.
  • Clover Health provides medical insurance services.\nIf you suffered a loss due to Clover Health Investment Corp.\'s misconduct, click here .\nAccording to a class action complaint filed against Clover Health, on October 6, 2020, the Company issued a press release announcing plans to become a publicly traded company via a merger with Social Capital Hedosophia Holdings Corp. III ("SCH").
  • On this news, shares of Clover dropped more than 12% from $13.95 on February 3, 2021, to $12.23 on February 4, 2021, representing a loss of $700 million in market capitalization.
  • The stock continued to tumble and now trades at just $8.50.\nContact us to learn more:\n'

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Clover Health Investments, Corp. (CLOV, CLOVW) f/k/a Social Capital Hedosophia Holdings Corp. III (IPOC)

Retrieved on: 
Friday, April 2, 2021
Legal, Professional services, Chamath Palihapitiya, Lisgar Collegiate Institute, Short selling, Hindenburg Research, Finance

On February 4, 2021, Hindenburg Research released a report entitled "Clover Health: How the King of SPACs Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation[.]"

Key Points: 
  • On February 4, 2021, Hindenburg Research released a report entitled "Clover Health: How the King of SPACs Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation[.]"
  • On this news, the Companys stock price fell $1.72 per share, or 12.3%, to close at $12.23 per share on February 4, 2021, thereby injuring investors.
  • On February 5, 2021, Clover issued a response in which it admitted, among other things, that it was aware of the DOJ investigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

CLOV 4-DAY DEADLINE ALERT: HAGENS BERMAN, National Trial Attorneys, Alerts Clover Health Investments (CLOV) Investors to April 6th Deadline in Securities Class Action, Encourages Investors with Losses to Contact the Firm

Retrieved on: 
Friday, April 2, 2021
Chamath Palihapitiya, Lisgar Collegiate Institute, Steve Berman, Securities fraud, Finance

SAN FRANCISCO, April 02, 2021 (GLOBE NEWSWIRE) -- Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now.

Key Points: 
  • SAN FRANCISCO, April 02, 2021 (GLOBE NEWSWIRE) -- Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now.
  • A securities fraud class action has been filed and certain investors may have valuable claims.
  • Hindenburg claimed that Clover concealed that the DOJ is actively investigating the company for illegal kickbacks and deceptive marketing practices.
  • Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CLOV and IRTC

Retrieved on: 
Wednesday, March 31, 2021
Articles, Chamath Palihapitiya, Lisgar Collegiate Institute, Limited liability company, Shareholder, Business, Finance

CEDARHURST, N.Y., March 30, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.

Key Points: 
  • CEDARHURST, N.Y., March 30, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.
  • Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (CLOV, CLOVW, IPOC)
    Class Period: 10/6/2020 - 2/4/2021 and/or in connection with the December 2020 merger of Clover and Social Capital III.
  • Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above, by calling toll-free at 1-833-835-1495 or by email ([email protected]).
  • Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Clover Health Investments (CLOV) Investors to April 6th Application Deadline in Securities Class Action, Encourages Investors with Losses to Contact its Attorneys Now

Retrieved on: 
Sunday, March 28, 2021
Chamath Palihapitiya, Lisgar Collegiate Institute, Steve Berman, Securities fraud, Finance

SAN FRANCISCO, March 28, 2021 (GLOBE NEWSWIRE) -- Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now.

Key Points: 
  • SAN FRANCISCO, March 28, 2021 (GLOBE NEWSWIRE) -- Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now.
  • A securities fraud class action has been filed and certain investors may have valuable claims.
  • Hindenburg claimed that Clover concealed that the DOJ is actively investigating the company for illegal kickbacks and deceptive marketing practices.
  • Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CLOV and IRTC

Retrieved on: 
Wednesday, March 24, 2021
Articles, Chamath Palihapitiya, Lisgar Collegiate Institute, Limited liability company, Shareholder, Business, Finance

CEDARHURST, N.Y., March 23, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.

Key Points: 
  • CEDARHURST, N.Y., March 23, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.
  • Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (CLOV, CLOVW, IPOC)
    Class Period: 10/6/2020 - 2/4/2021 and/or in connection with the December 2020 merger of Clover and Social Capital III.
  • Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above, by calling toll-free at 1-833-835-1495 or by email ([email protected]).
  • Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Clover Health Investments (CLOV) Investors of Securities Class Action and Approaching Deadline, Encourages Investors with Losses to Contact its Attorneys

Retrieved on: 
Monday, March 22, 2021
Chamath Palihapitiya, Lisgar Collegiate Institute, Steve Berman, Securities fraud, Finance

SAN FRANCISCO, March 22, 2021 (GLOBE NEWSWIRE) -- Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now.

Key Points: 
  • SAN FRANCISCO, March 22, 2021 (GLOBE NEWSWIRE) -- Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now.
  • A securities fraud class action has been filed and certain investors may have valuable claims.
  • Hindenburg claimed that Clover concealed that the DOJ is actively investigating the company for illegal kickbacks and deceptive marketing practices.
  • Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.